NCT03371303

Brief Summary

The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 1, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 13, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

December 13, 2017

Status Verified

December 1, 2017

Enrollment Period

2.3 years

First QC Date

December 1, 2017

Last Update Submit

December 6, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • entry orders before hospitalization

    15 months

  • exit orders after hospitalization

    15 months

Study Arms (4)

diabetology

Other: collection of prescription data

cardiology

Other: collection of prescription data

rheumatology

Other: collection of prescription data

geriatrics

Other: collection of prescription data

Interventions

collection of prescription data before and after a hospitalization

cardiologydiabetologygeriatricsrheumatology

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients must be hospitalized in one of the services of a university hospital, in the following 4 disciplines: diabetology, geriatrics, cardiology and rheumatology

You may qualify if:

  • Patient social insured
  • Patient belonging to the general social security scheme
  • Patient followed in cardiology, rheumatology, geriatrics or diabetology departments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Marseille

Marseille, 13005, France

Location

MeSH Terms

Conditions

Diabetes MellitusHeart DiseasesRheumatic Diseases

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCardiovascular DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2017

First Posted

December 13, 2017

Study Start

November 1, 2017

Primary Completion

February 1, 2020

Study Completion

February 1, 2021

Last Updated

December 13, 2017

Record last verified: 2017-12

Locations